Share the news WhatsApp Facebook X LinkedIn “It’s been an absolute pleasure working with the CROS team. We are VERY fortunate to be working with a strong Project Management team
Share the news WhatsApp Facebook X LinkedIn CRO Solutions and it’s sisters company, the Medicines Evaluation Unit, have recently partnered with Arxx Therapeutics. We happy to share that, with the
Share the news WhatsApp Facebook X LinkedIn Two-part Phase 1b trial will evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profile of inhaled pan-JAK inhibitor KN-002 Study is being conducted at
Share the news WhatsApp Facebook X LinkedIn The initiation of the Phase 2 study in patients in the United Kingdom (UK) follows the successful completion of dosing in the Phase 1 study
